| |
| Alle Journale wurden nach durchsucht |
Treffer 11961 - 11970 von 11970 |
|
|
|---|
11961. Berger R;
Frey B;
Hülsmann M;
Koller-Strametz J;
Pacher R;
Sima I;
Stanek B
Delayed effects of one-year treatment with low-dose as compared with high-dose enalapril on morbidity and mortality of patients with severe heart failure
Enalapril bei schwerer Herzinsuffizienz - Studienpopulation
Journal of Clinical and Basic Cardiology 1998; 1 (1): 19-24
Number of all randomized patients (all patients-treated cohort and study completing cohort) and number of drop outs at month 0, 15, 18, 24, 30 and 36, as allocated to the low-dose extension group and to the high-dose extension group. Keywords: Enalapril,
Enalapril,
Patient,
Patient,
Randomisierung,
randomization,
Schema,
Studie,
study
|
|
|
11962. Berger R;
Frey B;
Hülsmann M;
Koller-Strametz J;
Pacher R;
Sima I;
Stanek B
Delayed effects of one-year treatment with low-dose as compared with high-dose enalapril on morbidity and mortality of patients with severe heart failure
Enalapril bei schwerer Herzinsuffizienz - Blutdruck, Plasmakreatinin
Journal of Clinical and Basic Cardiology 1998; 1 (1): 19-24
Mean changes +/- SEM in systolic and diastolic blood pressure and in plasma creatinine from baseline to months 15, 18, 24, 30 and 36 in the low-dose extension group (open bars, n = 41) and in the high-dose extension group (black bars, n = 39). Mean changes +/- SEM in plasma creatinine from baseline to months 15, 18, 24, 30 and 36 in the low-dose extension group (open bars, n = 38) and in the high-dose extension group (black bars, n = 34). Keywords: blood pressure,
Blutdruck,
Diagramm,
Enalapril,
Enalapril,
plasma creatinine,
Plasmakreatinin,
Schwere Herzinsuffizienz,
severe heart failure,
Studie,
study
|
|
|
11963. Berger R;
Frey B;
Hülsmann M;
Koller-Strametz J;
Pacher R;
Sima I;
Stanek B
Delayed effects of one-year treatment with low-dose as compared with high-dose enalapril on morbidity and mortality of patients with severe heart failure
Enalapril bei schwerer Herzinsuffizienz - NYHA
Journal of Clinical and Basic Cardiology 1998; 1 (1): 19-24
Mean changes +/- SEM in NYHA functional class from baseline to months 15, 18, 24, 30 and 36 in the low-dose extension group (open bars, n = 41) and in the high-dose extension group (black bars, n = 40). Keywords: Diagramm,
Enalapril,
Enalapril,
NYHA,
NYHA-Stadium,
Schwere Herzinsuffizienz,
severe heart failure,
Studie,
study
|
|
|
11964. Berger R;
Frey B;
Hülsmann M;
Koller-Strametz J;
Pacher R;
Sima I;
Stanek B
Delayed effects of one-year treatment with low-dose as compared with high-dose enalapril on morbidity and mortality of patients with severe heart failure
Enalapril bei schwerer Herzinsuffizienz - Design
Journal of Clinical and Basic Cardiology 1998; 1 (1): 19-24
Flow chart. E, enalapril; BID, twice daily doses; Clin. exam., clinical examination; Lab., routine laboratory. Keywords: Design,
Design,
dosage,
Dosierung,
Enalapril,
Enalapril,
Schema,
Studie,
study
|
|
|
11965. Stoschitzky K;
Lindner W;
Zernig G
Racemic beta-blockers - fixed combinations of different drugs
Propranolol - Strukturformel
Journal of Clinical and Basic Cardiology 1998; 1 (1): 15-19
Structural formula of the (R)- and (S)-enantiomers of propranolol which behave like mirror images. The asymmetric carbon atom is marked by an asterisk. Keywords: beta-blocker,
Betablocker,
Enantiomer,
enantiomers,
Propranolol,
Propranolol,
racemates,
Razemat,
structure,
Strukturformel
|
|
|
11966. Stoschitzky K;
Lindner W;
Zernig G
Racemic beta-blockers - fixed combinations of different drugs
Propranolol, Propanfenon - Strukturformel
Journal of Clinical and Basic Cardiology 1998; 1 (1): 15-19
Structural similarity of (S)-propranolol and (S)-propafenone. The framed part shows the aminoalkanol chain that is common to all beta-blockers currently used in clinical practice (except sotalol). Hence, the asymmetric carbon atom (marked by an asterisk) is a common feature of all beta-adrenoceptor antagonists. Keywords: beta-blocker,
Betablocker,
Propafenon,
propafenone,
Propranolol,
Propranolol,
racemates,
Razemat,
structure,
Strukturformel
|
|
|
11967. Erdmann E
Chronic cardiac insufficiency: therapy with beta-adrenergic blockers
CIBIS-II - Bisoprolol-Titration
Journal of Clinical and Basic Cardiology 1998; 1 (1): 10-14
The titration of bisoprolol in patients of CIBIS-II-study Keywords: Bisoprolol,
Bisoprolol,
CIBIS-II,
CIBIS-II,
Diagramm,
dose,
Dosierung,
Studie,
study,
titration,
titration
|
|
|
11968. Erdmann E
Chronic cardiac insufficiency: therapy with beta-adrenergic blockers
CIBIS II - Überleben
Journal of Clinical and Basic Cardiology 1998; 1 (1): 10-14
Survival curves (Kaplan-Meier) of CIBIS-patients with and without history of myocardial infarction. Keywords: Bisoprolol,
Bisoprolol,
CIBIS-II,
CIBIS-II,
Diagramm,
Kaplan-Meier-curve,
Kaplan-Meier-Kurve,
mortality,
Mortalität,
myocardial infarction,
Myokardinfarkt,
Studie,
study
|
|
|
11969. Erdmann E
Chronic cardiac insufficiency: therapy with beta-adrenergic blockers
Herz - Kontraktionskraft
Journal of Clinical and Basic Cardiology 1998; 1 (1): 10-14
In human myocardium force of contraction increases with the frequency. This is, however, only true for a normal, non-failing myocardium. In heart failure the force of contraction decreases with increasing frequency of contraction. Thus, a high heart rate may lead to deterioration of the patient. Keywords: contraction force,
Diagramm,
heart failure,
heart rate,
Herzfrequenz,
Herzinsuffizienz,
Kontraktionskraft,
myocardium,
Myokard,
NYHA,
NYHA-Stadium
|
|
|
11970. Borchard U
Pharmacological properties of beta-adrenoceptor blocking drugs
Betablocker - Metabolismus
Journal of Clinical and Basic Cardiology 1998; 1 (1): 5-9
Metabolic pathways of ß-adrenoceptor blocking drugs in the liver. Glu = Glucuronide. The numbers indicate the following metabolic pathways: 1) Glucuronidation of the drug at the OH group of the side chain. 2) Aromatic hydroxylation and subsequent glucuronidation partly combined with the steps described under 3 and 4 (---). 3) Oxidative desamination. 4) Ether cleavage to phenol. 5) N-desalcylation. Keywords: beta-blocker,
Betablocker,
Leber,
liver,
metabolism,
Metabolismus,
Schema
|
|
|
| |
|
Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
